Mr. Stuart M. Essig is Independent Director of St. Jude Medical Inc., since 1999. Mr. Essig is currently the Chairman of the Board of Directors of Integra LifeSciences Holdings Corporationrationration, a manufacturer of medical devices and implants, a position he has held since January 2012. Prior to such role, Mr. Essig served as Integra?s Chief Executive Officer from December 1997 until January 2012 and its President from December 1997 until November 2010. In addition, he has served as a director since he joined Integra in December 1997. Prior to joining Integra, Mr. Essig supervised the medical technology practice at Goldman, Sachs & Co. as a managing director. Mr. Essig has also served on the Board of Directors of the Advanced Medical Technology Association, a trade association that represents the medical device industry.
Age: 50 Director Since 1999
The company has Return on Asset of 10.02 % which means that on every $100 spent on asset it made $10.02 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.48 % implying that it generated $18.48 on every 100 dollars invested.
The company has 3.36 B in debt with debt to equity (D/E) ratio of 0.88 which is OK given its current industry classification. St Jude Medical Inc has Current Ratio of 2.05 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
Entity SummarySt. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. St Jude Medical Inc [STJ] is traded on New York Stock Exchange in USA. It is located in Saint Paul, MN and employs 15,000 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| STJ NYSE
St Jude Medical Inc
St Jude Medical Inc has less than 39.38 (%) percent chance of experiencing financial distress in the next 2 years of operations.
St Jude price boundaries
Promote St Jude and Stuart Essig